Proven Checks Buyers Miss In A Batch Manufacturing Record
The first commercial batch from a new intermediate supplier is not a formality. Here is the checklist, the five approval outcomes, and how to log the call.
intermediate sourcing
ICH Q11 Starting Material Selection: A Practical Guide for Pharmaceutical Intermediate Buyers
Learn how ICH Q11 starting material rules affect pharmaceutical intermediate sourcing—supplier boundaries, COA red flags, and a practical buyer’s checklist.
Intermediate Pricing: 6 Cost Drivers Explained
A manufacturer’s guide to the six cost layers behind pharmaceutical intermediate pricing—raw materials, synthesis yields, chiral chemistry, purification, waste treatment, and scale—helping buyers evaluate competing quotes and identify hidden risks.
LCZ696 Intermediate Synthesis: Key Building Blocks & Quality Control for Sacubitril/Valsartan Production
A guide to LCZ696 intermediate synthesis: the five-step route, key quality control parameters, and co-crystal purity requirements for consistent API performance.
Resmetirom Intermediates: A Buyer’s Guide to Sourcing the First Approved MASH Drug Precursors
A practical sourcing guide for resmetirom intermediates covering the synthesis pathway, key building blocks, quality checkpoints, old vs new manufacturing routes, and the MASH drug supply chain outlook.